Heinz Lubenau, Co-Founder & CEO will be presenting VAXIMM at the upcoming Immuno-Oncology Innovation Forum.
— Sachs Associates (@SachsAssociates) April 13, 2021
e-Meet VAXIMM at #Sachs_IOIF
More info @ https://t.co/tMBHnCypoC pic.twitter.com/NlHmK8mXcf